• Celsius Holdings recently reported that growth in its core energy drink business has slowed in line with management’s expectations, prompting several major firms such as UBS, Roth Capital, Bank of America, Morgan Stanley, BNP Paribas, Bernstein, and JPMorgan to reassess their analysis of the company while maintaining generally constructive coverage.
• Analysts now frame the deceleration, regulatory headlines, and fair value estimate reductions as part of a timing and optimization phase rather than a structural setback, even as Celsius trades on earnings multiples above sector averages and continues to draw attention for its rapid revenue expansion and health-focused portfolio, including the Alani Nu brand.
• We’ll now examine how this management-expected slowdown in Celsius’s core business may reshape the company’s investment narrative and risk-reward balance.

This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

Celsius Holdings Investment Narrative Recap

To own Celsius today, you generally have to believe the company can translate its still-rapid revenue growth and health-focused portfolio into durable profits, even as its core energy drink business slows in line with management’s expectations. The latest deceleration and fair value trims mainly sharpen attention on the key near term catalyst: execution on optimization and integration, especially around Alani Nu. The biggest immediate risk remains rich valuation multiples if growth or margins disappoint meaningfully.

The most relevant recent update here is the modest reduction in fair value estimates to about US$58.52, alongside continued constructive ratings from major firms. That reset acknowledges softer category trends and regulatory headlines, even as Q1 2026 results showed very strong year on year revenue and earnings growth. How well Celsius converts that growth into sustained margin improvement will likely drive how investors reassess both the upside catalyst and the valuation risk from here.

Yet beneath the upbeat growth story, tightening scrutiny of Celsius and Alani Nu’s marketing and product safety is a risk investors should be aware of...

Celsius Holdings' narrative projects $4.0 billion revenue and $610.2 million earnings by 2029.

Uncover how Celsius Holdings' forecasts yield a $58.52 fair value, a 76% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts already assumed Celsius would still lift earnings to about US$574.3 million by 2029, yet they flag that tighter regulation and shifting consumer tastes toward more natural products could challenge that view, so your own stance on these risks really matters.

Explore 14 other fair value estimates on Celsius Holdings - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Celsius Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Celsius Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Celsius Holdings' overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 7 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.